Johnny T. Ottesen

Roskilde, 4000, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Mathematical modeling of JAK2V617F clonal expansion in a general population cohort.

Mathematical modeling of JAK2V617F clonal expansion in a general population cohort.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 17, 2026

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Journal: Mathematical biosciences

Published: January 22, 2026

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Journal: Mathematical biosciences

Published: January 22, 2026

The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortality.

The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all-cause mortality.

Journal: Journal of internal medicine

Published: November 06, 2025

Modeling the evolutionary dynamics of clonal hematopoiesis.

Modeling the evolutionary dynamics of clonal hematopoiesis.

Journal: Nature genetics

Published: August 15, 2025

Response to comment on: Toward an optimal contraception dosing strategy.

Response to comment on: Toward an optimal contraception dosing strategy.

Journal: PLoS computational biology

Published: September 04, 2024

Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms.

Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms.

Journal: Frontiers in immunology

Published: February 09, 2024

Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study.

Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study.

Journal: Blood cancer journal

Published: September 28, 2023

Aging, Inflammation, and Comorbidity in Cancers-A General In Silico Study Exemplified by Myeloproliferative Malignancies.

Aging, Inflammation, and Comorbidity in Cancers-A General In Silico Study Exemplified by Myeloproliferative Malignancies.

Journal: Cancers

Published: August 31, 2023

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.

Journal: Frontiers in immunology

Published: June 15, 2023

Bayesian parameter estimation for phosphate dynamics during hemodialysis.

Bayesian parameter estimation for phosphate dynamics during hemodialysis.

Journal: Mathematical biosciences and engineering : MBE

Published: March 10, 2023

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.

Journal: Frontiers in oncology

Published: February 28, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026